Advisors Asset Management Inc. Acquires 14,992 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

Advisors Asset Management Inc. increased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 41.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 51,226 shares of the company’s stock after purchasing an additional 14,992 shares during the period. Advisors Asset Management Inc.’s holdings in Takeda Pharmaceutical were worth $728,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of TAK. Catalytic Wealth RIA LLC boosted its position in Takeda Pharmaceutical by 4.0% during the 2nd quarter. Catalytic Wealth RIA LLC now owns 21,703 shares of the company’s stock valued at $281,000 after acquiring an additional 841 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Takeda Pharmaceutical by 38.6% in the second quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock valued at $43,000 after purchasing an additional 859 shares during the last quarter. Hexagon Capital Partners LLC raised its holdings in Takeda Pharmaceutical by 34.3% in the third quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company’s stock worth $63,000 after purchasing an additional 1,129 shares in the last quarter. Gallacher Capital Management LLC lifted its position in shares of Takeda Pharmaceutical by 7.0% during the second quarter. Gallacher Capital Management LLC now owns 17,365 shares of the company’s stock valued at $225,000 after buying an additional 1,136 shares during the last quarter. Finally, Cutter & CO Brokerage Inc. boosted its holdings in shares of Takeda Pharmaceutical by 3.3% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 41,974 shares of the company’s stock valued at $543,000 after buying an additional 1,347 shares in the last quarter. 9.17% of the stock is currently owned by institutional investors.

Takeda Pharmaceutical Trading Down 0.4 %

NYSE TAK opened at $13.44 on Wednesday. Takeda Pharmaceutical Company Limited has a 52 week low of $12.57 and a 52 week high of $15.08. The company has a 50 day moving average price of $14.05 and a 200 day moving average price of $13.84. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.64. The firm has a market cap of $42.76 billion, a PE ratio of 23.17, a price-to-earnings-growth ratio of 0.25 and a beta of 0.54.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.